- Research article
- Open Access
Age-related pattern and monocyte-acquired haemozoin associated production of erythropoietin in children with severe malarial anaemia in Ghana
© Abugri et al.; licensee BioMed Central Ltd. 2014
- Received: 28 April 2014
- Accepted: 14 August 2014
- Published: 20 August 2014
Malaria continues to be a global health challenge, affecting more than half the world’s population and causing approximately 660,000 deaths annually. The majority of malaria cases are caused by Plasmodium falciparum and occur in sub-Saharan Africa. One of the major complications asscociated with malaria is severe anaemia, caused by a cycle of haemoglobin digestion by the parasite. Anaemia due to falciparum malaria in children has multifactorial pathogenesis, which includes suppression of bone marrow activity. Recent studies have shown that haemozoin, which is a by-product of parasite haemoglobin digestion, may play an important role in suppression of haemoglobin production, leading to anaemia. In this study we correlated the levels of erythropoietin (EPO), as an indicator of stimulation of haemoglobin production, to the levels of monocyte acquired haemozoin in children with both severe and uncomplicated malaria. There was a significantly negative correlation between levels of haemozoin-containing monocytes and EPO, which may suggest that haemozoin suppresses erythropoiesis in severe malaria. A multiple linear regression analysis and simple bar was used to investigate associations between various haematological parameters.
To examine the levels of erythropoietin in the age categories, the levels of erythropoietin was measured using a commercial Enyme-Linked Immunosorbent Assay (ELISA). Giemsa-stained blood smears were used to determine percentage pigment containing monocytes. The haemozoin containing monocytes was expressed as a percentage of the total number of monocytes. To obtain the number of haemozoin containing monocytes/μL the percentage of haemozoin containing monocytes was multiplied by the absolute number of monocytes/μL from the automated haematology analyzer.
The levels of erythropoietin in younger children (<3 years) was significantly higher than in older children with a similar degree of malaria anaemia (Hb levels) (p < 0.005). Haemozoin-containing monocytes were relatively higher in severe malaria anaemia patients compared to those with uncomplicated malaria (p < 0.001).
Age purportedly has a direct effect on background levels of erythropoietin. With corresponding decreased levels of erythropoietin in older children with the same degree of severe malarial anaemia, conceivably, the bone marrows of younger children with acute malaria may be less sensitive to erythropoietin.
- Severe Malaria
- Cerebral Malaria
- Uncomplicated Malaria
Malaria is an infectious disease and a major public health problem. Malaria can be uncomplicated or severe, often manifesting as severe anaemia, impaired consciousness or respiratory distress . Metabolic complications in severe malaria in children include hypoglycaemia and metabolic acidosis. Major clinical complications of severe malaria in non-immune adults include cerebral malaria, acute renal failure, pulmonary oedema and acute respiratory distress syndrome.
Malaria contributes significantly to the development of anaemia in sub-Saharan Africa and elsewhere, where the disease is prevalent . Indeed severe malarial anaemia (SMA), defined as as anaemia with haemoglobin (Hb) concentration of <5 g/dL with P. falciparum asexual parasitemia, in the absence of any other or additional identifiable cause of anaemia , is the most widespread complication of Plasmodium falciparum infection, especially among children (WHO, 2000). The anaemia of malaria has profound pathological effects on patients and its root cause is multifactorial and encompasses haemolysis, erythrophagocytosis, dyserythropoiesis, and ineffective erythropoiesis [4–6]. Its manifestations are also complex and defy accurate delineation. Blood transfusion as a treatment for malaria has very high risks because of the high incidence of HIV and other blood-borne infections.
In addition to direct destruction of infected erythrocytes by the malaria parasites during schizogony and the premature removal of non-parasitized erythrocytes, reversible suppression of erythropoiesis has also been reported to play a key role in its pathogenesis . Suppression of erythropoiesis means a failure of the bone marrow to respond adequately to the excessive removal of the erythrocytes by producing more erythrocytes and to alleviate the anaemia. The suppression of bone marrow function in severe anaemia patients with microscopically undetectable parasitaemia has been presumptively attributed to subpatent malaria parasites . However, subpatent parasitaemia cannot account fully for the suppression of bone marrow function. Haemozoin and inflammatory mediators have also been implicated in the suppression of bone marrow function [9, 10]. Their roles and the interplay between the various factors in the development of severe malaria anaemia have not been explicitly elucidated. The thrust of this study was therefore to investigate the level of erythropoietin and haemozoin in both severe malaria anaemia and uncomplicated malaria in Ghanaian children. To achieve this, levels of erythropoietin and haemozoin containing monocytes were measured using approved protocols.
This study was hospital-based,, involving children aged 1–13 years, admitted to the emergency unit of the Department of Child Health (DCH) of the Korle-Bu Teaching Hospital and outpatients at the Korle-Bu Polyclinic, both in Accra, Ghana during the peak malaria transmission season (July to August, 2005). The patients were examined clinically by a physician and laboratory investigations including haematology, microscopy and clinical chemistry carried out.
Parents/guardians of patients gave informed consent prior to recruitment. Demographical, clinical history and management/outcomes were also documented. This study formed part of a larger one, which was approved by the Institutional Review Board (IRB) and the Scientific and Technical Committee (STC) of the Noguchi Memorial Institute for Medical Research (NMIMR), College of Health Sciences, University of Ghana, Legon. The study also received the approval of the Scientific and Ethical Review Committee of the University of Ghana Medical School, College of Health Sciences, and University of Ghana.
Inclusion criteria for malaria patients
Inclusion criteria for malaria patients were fever (≥37.5°C) measured within 24 hours of admission, malaria parasitaemia, and at least one other sign of malaria (vomiting, diarrhoea, malaise etc.). Children with other clinical presentations other than malaria or that had a positive sickling test were excluded from the study. Patients were categorized as uncomplicated and severe malaria based on previously established clinical characterization, haematological and other indices [3, 11].
Severe malaria cases had haemoglobin (Hb) ≤5g/dL and any level of peripheral blood Plasmodium falciparum parasitaemia, were fully conscious without severe bleeding or convulsions and had no other cause of anaemia. SMA also included patients who were unconscious with a Blantyre coma score of ≤3, duration of coma >60 minutes, any Hb value, any parasitaemia and no other neurological diseases . Uncomplicated malaria cases were patients who were fully conscious, had malaria parasitaemia and no severe complication as described above. The physician examined the patients clinically and other causes of anaemia such as helminth infection, nutritional deficiency and HIV infection were precluded.
Blood collection for laboratory analyses
Venous blood was collected into sterile vacutainer tubes containing heparin and EDTA for routine diagnostic purposes. Plasma was obtained by centrifugation using the poor-platelet plasma (PPP) method. In this method, the vacutainer tube containing blood samples was centrifuged at 65 × g for 15 minutes at room temperature. The supernatant which is the Rich-Platelet-Protein (RPP) fraction was taken without disturbing the buffy coat and put into another tube. This was again centrifuged at 960 × g for 10 minutes. The supernatant which is the PPP was then collected and stored at −80 degrees Celsius.
Thick and thin blood films obtained at enrollment prior to therapy were stained with Giemsa for detection, identification and enumeration of Plasmodium. Peripheral parasite density was determined from thick films based on the number of asexual forms against 300 white blood cells (WBCs) and the value multiplied by each individual’s WBC count from the automatic haematology analyzer (SYSMEX, Japan) to obtain parasites per μL of blood. Absolute parasite counts were calculated for each child using either thin films (counting parasitized RBCs per 500 RBCs), or from thick films (counting parasitized RBCs per 300 WBCs).The Quantikine IVD Epo ELISA kit was used to determine erythropoietin levels following the manufacturer’s instructions.
Statistical analyses were carried out using Sigmaplot 12 (http://www.sigmaplot.com) and graphpad prism 5. Spearman’s rank coefficients were calculated to assess correlations between various parameters and levels of haemoglobin as well as levels of haemozoin containing monocytes and neutrophils.
Clinical characteristics of study participants
Clinical characteristics and laboratory parameters of Ghanaian children with complicated and uncomplicated malaria
Mean age (Years)
Mean haemoglobin (g/dL)
Mean parasitaemia (parasites/uL)
Erythropoietin and other haematogical correlates
Role of monocyte acquired haemozoin
The study confirms the finding that younger children produce higher levels of erythropoietin compared to older children with a similar degree of anaemia (Hb levels) . This finding is significant because it could partly explain the finding that severe malarial anaemia is more common in younger children whose bone marrow needs to be stimulated by high levels of EPO to replenish the loss of erythrocytes by producing new erythrocytes rapidly. Age and haemoglobin levels are reportedly independent variables with respect to erythropoietin responses. Apparently, erythropoietin response declines during development at a similar degree of anaemia. Age purportedly, has a direct effect on the background level of production of erythropoietin. With the corresponding decreased levels of erythropoietin in older children with the same degree of severe malarial anaemia, conceivably, the bone marrows of the younger children with acute malaria may be less sensitive to erythropoietin. Confirmation of this theory will require longitudinal studies including examination of bone biopsies from children with SMA, which is beyond the scope of the present preliminary, cross-sectional study.
Previous studies have established the ability of erythropoietin to cross the blood/brain barrier and to provide protection against experimental injury as well as act as a tissue protective cytokine [13, 14]. It is thus plausible to suggest that the high levels of erythropoietin in younger children with anaemia as compared to older children with relatively the same degree of anaemia may, presumably, protect them against tissue damage. It may also contribute to the low frequency of cerebral malaria in relatively younger children .
In the present study percentage haemozoin containing monocytes were significantly elevated in severe malaria anaemia compared to uncomplicated malaria. This finding corroborates earlier findings which implicated haemozoin in malaria pathogenesis through the suppression of erythropoiesis directly or in synergy with proinflammatory cytokines . The elevated levels of haemozoin in severe malaria anaemia could therefore be accounted for by the increased pathogenesis therein. Besides the acquisition of haemozoin by human monocytes purportedly plays a crucial role in triggering severe malaria . This study also showed a significant positive correlation between levels of erythropoietin and haemozoin containing monocytes. This corroborates earlier findings that demonstrated that haemozoin directly has an effect in the induction of apoptosis in nascent erythroid cells in malaria anaemia . The inadequate erythropoietic response in the presence of high levels of erythropoietin, presumably results from the release of cytokines, chemokines and lipo-peroxides upon the exposure to haemozoin and these synergistically could lead to the concomitant inhibition of erythropoiesis [16, 17]. Taken together our findings are consistent with extant literature and support critical key findings in malaria pathogenesis that implicate haemozoin in the direct and indirect induction of dyserythropoiesis.
In conclusion this study has confirmed earlier findings that erythropoietin production is age-related with younger children having the ability to produce more erythropoietin during acute malaria than older children. This study also suggests the involvement of haemozoin a parasite product in the inhibition of erythropoiesis as the seeming robust production of erythropoietin did not translate into higher Hb levels.
The authors are grateful to the study participants and all the staff of the immunology department of Noguchi Memorial institute for Medical Research. This study received financial support from United Nations Development Programme/World Bank/World Health Organization Special Programme for Research and Training in Tropical Diseases (TDR) (Multilateral Initiative on Malaria/TDR grant 980037) and the Programme for Enhancement of Research Capacity in Developing Countries, Danish International Development Assistance (DANIDA).
- Mockenhaupt FP, Ehrhardt S, Burkhardt J, Bosomtwe SY, Laryea S, Anemana SD, Otchwemah RN, Cramer JP, Dietz E, Gellert S, Bienzle U: Manifestation and outcome of severe malaria in children in northern Ghana. Am J Trop Med Hyg. 2004, 71 (2): 167-172.PubMedGoogle Scholar
- Kurtzhals JA, Helleberg M, Goka BQ, Akanmori BD: Severe malaria in west African children. Lancet. 2003, 361 (9366): 1393-PubMedView ArticleGoogle Scholar
- Kurtzhals JA, Goka BQ, Akanmori BD, Hviid L: The importance of strict patient definition in studies of malaria pathogenesis. Trends Parasitol. 2001, 17 (7): 313-314. 10.1016/S1471-4922(01)01950-X.PubMedView ArticleGoogle Scholar
- Chang KH, Stevenson MM: Malarial anaemia: mechanisms and implications of insufficient erythropoiesis during blood-stage malaria. Int J Parasitol. 2004, 34 (13–14): 1501-1516.PubMedView ArticleGoogle Scholar
- Lamikanra AA, Brown D, Potocnik A, Casals-Pascual C, Langhorne J, Roberts DJ: Malarial anemia: of mice and men. Blood. 2007, 110 (1): 18-28. 10.1182/blood-2006-09-018069.PubMedView ArticleGoogle Scholar
- Perkins DJ, Were T, Davenport GC, Kempaiah P, Hittner JB, Ong’echa JM: Severe malarial anemia: innate immunity and pathogenesis. Int J Biol Sci. 2011, 7 (9): 1427-1442. 10.7150/ijbs.7.1427.PubMedPubMed CentralView ArticleGoogle Scholar
- Kurtzhals JA, Rodrigues O, Addae M, Commey JO, Nkrumah FK, Hviid L: Reversible suppression of bone marrow response to erythropoietin in Plasmodium falciparum malaria. Br J Haematol. 1997, 97 (1): 169-174. 10.1046/j.1365-2141.1997.82654.x.PubMedView ArticleGoogle Scholar
- Helleberg M, Goka BQ, Akanmori BD, Obeng-Adjei G, Rodriques O, Kurtzhals JA: Bone marrow suppression and severe anaemia associated with persistent Plasmodium falciparum infection in African children with microscopically undetectable parasitaemia. Malar J. 2005, 4 (1): 56-10.1186/1475-2875-4-56.PubMedPubMed CentralView ArticleGoogle Scholar
- Casals-Pascual C, Kai O, Cheung JO, Williams S, Lowe B, Nyanoti M, Williams TN, Maitland K, Molyneux M, Newton CR, Peshu N, Watt SM, Roberts DJ: Suppression of erythropoiesis in malarial anemia is associated with hemozoin in vitro and in vivo. Blood. 2006, 108 (8): 2569-2577. 10.1182/blood-2006-05-018697.PubMedView ArticleGoogle Scholar
- Awandare GA, Ouma Y, Ouma C, Were T, Otieno R, Keller CC, Davenport GC, Hittner JB, Vulule J, Ferrell R, Ong’echa JM, Perkins DJ: Role of monocyte-acquired hemozoin in suppression of macrophage migration inhibitory factor in children with severe malarial anemia. Infect Immun. 2007, 75 (1): 201-210. 10.1128/IAI.01327-06.PubMedPubMed CentralView ArticleGoogle Scholar
- Kurtzhals JA, Adabayeri V, Goka BQ, Akanmori BD, Oliver-Commey JO, Nkrumah FK, Behr C, Hviid L: Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria. Lancet. 1998, 351 (9118): 1768-1772. 10.1016/S0140-6736(97)09439-7.PubMedView ArticleGoogle Scholar
- O’Donnell A, Premawardhena A, Arambepola M, Allen SJ, Peto TE, Fisher CA, Rees DC, Olivieri NF, Weatherall DJ: Age-related changes in adaptation to severe anemia in childhood in developing countries. Proc Natl Acad Sci U S A. 2007, 104 (22): 9440-9444. 10.1073/pnas.0703424104.PubMedPubMed CentralView ArticleGoogle Scholar
- Brines ML, Ghezzi P, Keenan S, Agnello D, de Lanerolle NC, Cerami C, Itri LM, Cerami A: Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury. Proc Natl Acad Sci U S A. 2000, 97 (19): 10526-10531. 10.1073/pnas.97.19.10526.PubMedPubMed CentralView ArticleGoogle Scholar
- Ghezzi P, Brines M: Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell Death Differ. 2004, 11 (Suppl 1): S37-S44.PubMedView ArticleGoogle Scholar
- Lamikanra AA, Theron M, Kooij TWA, Roberts DJ: Hemozoin (malarial pigment) directly promotes apoptosis of erythroid precursors. PLoS One. 2009, 4 (12): e8446-10.1371/journal.pone.0008446.PubMedPubMed CentralView ArticleGoogle Scholar
- Perkins DJ, Weinberg JB, Kremsner PG: Reduced interleukin-12 and transforming growth factor beta1 in severe childhood malaria: Relationship of cytokine balance with disease severity. J Infect Dis. 2000, 182: 988-992. 10.1086/315762.PubMedView ArticleGoogle Scholar
- Awandare GA, Kempaiah P, Ochiel DO, Piazza P, Keller CC, Perkins DJ: Mechanisms of erythropoiesis inhibition by malarial pigment and malaria-induced proinflammatory mediators in an in vitro model. Am J Hematol. 2011, 86: 155-162. 10.1002/ajh.21933.PubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.